Radiation response a meltdown in reason

July 14, 2011 in Cancer

The possibility that low doses of radiation may prevent or delay the progression of cancer is being explored by a Flinders University research team led by Professor Pam Sykes (pictured) in a move that runs counter to the widely held perception that exposure to any radiation is harmful.

Professor Sykes, recently appointed to the University’s Strategic Professorship in Preventive Biology in the Flinders Centre for Cancer Prevention and Control says the public panic in response to nuclear accidents such as that at Fukushima in Japan is the result of a general ignorance about radiation.

“We have to ensure that radiation is respected and we have to understand what damage radiation can cause – but radiation is not the poison, the dose is,” Professor Sykes said.

“We need radiation in our environment, just as we need vitamins and minerals. Too much is a problem, too little is a problem,” she said.

“Chernobyl was obviously a disaster but there was no increase in leukaemia, solid tumours or birth defects among the 335,000 people who were evacuated and who received less than 100 milliSieverts of radiation – that’s five times the dose I’m allowed as a radiation worker.

“There was an increase in thyroid tumours but we’re not sure how much that related to the fact that everyone was screened for thyroid tumours, which wouldn’t normally happen.

“It’s now been accepted that they should not have evacuated so many people because the biggest detriment from Chernobyl was that they were dramatically disadvantaged, both economically and socially. Many suffered depression thinking they were going to die of cancer.

“And the frightening thing is that it’s been estimated that throughout Europe there were over 100,000 wanted pregnancies aborted, and these were people who didn’t live anywhere near Chernobyl.”

Professor Sykes’ research, which involves doses of radiation that are up to three orders of magnitude lower than those used by other investigators, has been funded by the US Department of Energy Low Dose Radiation Research Program for almost 10 years.

“Using a transgenic mouse that is very sensitive to stressors, we have identified regions in the dose range that cause different biological effects,” she said.

“Some of our colleagues in Germany and Oxford have shown that low doses of radiation to cells in culture trigger a mechanism which removes pre-tumour cells. We’re now working to see if we can identify this response in a mouse.

“If we can understand these mechanisms, we can manipulate them to prevent cancer,” adding it might be “several years” before the potential to humans could be confirmed.

Studies in Canada and Japan have also shown that low doses of radiation given to mice delay the onset of cancer, and reduce the symptoms of diabetes and atherosclerosis, improving the span and quality of life of the affected animals.

Professor Sykes and her team are currently examining low dose therapy in reducing or preventing prostate cancer, with a grant from the Prostate Council Foundation of Australia.

Provided by Flinders University

4 /5 (2 votes)  

Rank 4 /5 (2 votes)
Relevant PhysicsForums posts

More news stories

Research examines new methods for managing digestive health

Research presented at Digestive Disease Week (DDW) explores new methods for managing digestive health through diet and lifestyle.

Cancer created 16 minutes ago | popularity not rated yet | comments 0

New colonoscope provides ground-breaking view of colon

A ground-breaking advance in colonoscopy technology signals the future of colorectal care, according to research presented today at Digestive Disease Week(DDW). Additional research focuses on optimizing the minimal withdrawal ...

Cancer created 14 hours ago | popularity 5 / 5 (2) | comments 0

ASCO: combo antibody therapy effective for melanoma

(HealthDay)—Concurrent use of two immune checkpoint antibodies—ipilimumab and nivolumab—may be effective for the treatment of advanced melanoma, according to a proof-of-principal study presented in ...

Cancer created May 17, 2013 | popularity not rated yet | comments 0

Risk factors ID'd for poor cutaneous cell CA outcomes

(HealthDay)—The risks of metastasis and death associated with cutaneous squamous cell carcinoma (CSCC) are low, but significant, and risk factors for poor outcome include tumor diameter, invasion beyond ...

Cancer created May 17, 2013 | popularity not rated yet | comments 0 | with audio podcast

Physical & emotional impairments common, often untreated in people with cancer

A new review finds cancer survivors suffer a diverse and complex set of impairments, affecting virtually every organ system. Writing in CA: A Cancer Journal for Clinicians, Julie Silver, M.D., associate professor at Harvar ...

Cancer created May 17, 2013 | popularity not rated yet | comments 0


Consuming coffee linked to lower risk of detrimental liver disease, study finds

Regular consumption of coffee is associated with a reduced risk of primary sclerosing cholangitis (PSC), an autoimmune liver disease, Mayo Clinic research shows. The findings were being presented at the Digestive Disease ...

Ketamine shows significant therapeutic benefit in people with treatment-resistant depression

Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic, according to the largest ketamine clinical trial to-date led by researchers from the ...

New research identifies practice changes to improve value and quality of GI procedures

There are significant cost and risk factors associated with two procedures commonly used to diagnose or treat gastrointestinal problems, according to research presented at Digestive Disease Week (DDW).

New research identifies risks, interventions for children's GI health

An increasing number of U.S. children are experiencing gastrointestinal issues that require interventions to resolve, according to research presented at Digestive Disease Week (DDW).

US psychiatry gets makeover in new manual

The latest makeover to a massive psychiatric tome honored by some, reviled by others and even called the "Bible" of mental disorders is being released Saturday with a host of new changes.

AIDS science at 30: 'Cure' now part of lexicon

Big names in medicine are set to give an upbeat assessment of the war on AIDS on Tuesday, 30 years after French researchers identified the virus that causes the disease.